Trojan horses and guided missiles: targeted therapies in the war on arthritis. (Q38367194)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

review article

1 reference

title

Trojan horses and guided missiles: targeted therapies in the war on arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

Costantino Pitzalis

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Shimobi C Onuoha

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

English

0 references

publication date

3 March 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

Nature Reviews Rheumatology

1 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

328-337

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25734971 AND SRC:MED&resulttype=core&format=json

Polymer--drug conjugates as nano-sized medicines

1 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

How to stabilize phospholipid liposomes (using nanoparticles).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

State-of-the-art: rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

CD44 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

State of the art in PEGylation: the great versatility achieved after forty years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

The vasculature in rheumatoid arthritis: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Hypoxia--a key regulator of angiogenesis and inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Suppression of neovascularization and experimental arthritis by D-form of anti-flt-1 peptide conjugated with mini-PEG™

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Pharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Structural and biologic characterization of pegylated recombinant IFN-alpha2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Syntheses of click PEG-dexamethasone conjugates for the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Drug entrapment in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Strategies in the design of nanoparticles for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Temperature-modulated noncovalent interaction controllable complex for the long-term delivery of etanercept to treat rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Targeted chemo-photothermal treatments of rheumatoid arthritis using gold half-shell multifunctional nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Designing micro- and nano-particles for treating rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Renal clearance of quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

The potential of liposomal drug delivery for the treatment of inflammatory arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Folate‐targeted nanoparticles show efficacy in the treatment of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Systemic delivery of small interfering RNA targeting the interleukin-2/15 receptor β chain prevents disease progression in experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

TNF-α gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Cell-penetrating peptides released from thermosensitive nanoparticles suppress pro-inflammatory cytokine response by specifically targeting inflamed cartilage explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

An intra-articular salmon calcitonin-based nanocomplex reduces experimental inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Functionalized STAT1 siRNA Nanoparticles Regress Rheumatoid Arthritis in A Mouse Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Emerging cell and cytokine targets in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Gene expression profiling and functional analysis of angiogenic markers in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

The essential role of chemokines in the selective regulation of lymphocyte homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Molecular mechanisms of cell recruitment to inflammatory sites: general and tissue-specific pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Identification of synovium-specific homing peptides by in vivo phage display selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Simultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances efficacy in an in vivo model of arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Murine analogues of etanercept and of F8-IL10 inhibit the progression of collagen-induced arthritis in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Antibody-based delivery of IL4 to the neovasculature cures mice with arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Targeted delivery of cytokine therapy to rheumatoid tissue by a synovial targeting peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

HSA nanocapsules functionalized with monoclonal antibodies for targeted drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Fumagillin prodrug nanotherapy suppresses macrophage inflammatory response via endothelial nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Hyaluronate-gold nanoparticle/tocilizumab complex for the treatment of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Therapeutic antibodies for autoimmunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

A novel bispecific antibody targeting tumor necrosis factor α and ED-B fibronectin effectively inhibits the progression of established collagen-induce arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Polymers and drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

New learnings on the pathophysiology of RA from synovial biopsies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Paul Ehrlich's magic bullet concept: 100 years of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Development of a novel recombinant biotherapeutic with applications in targeted therapy of human arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Ionic complex systems based on hyaluronic acid and PEGylated TNF-related apoptosis-inducing ligand for treatment of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Hyaluronan nanoparticles bearing γ-secretase inhibitor: in vivo therapeutic effects on rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Tumour necrosis factor-alpha (TNF-alpha) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Treatment of experimental arthritis by targeting synovial endothelium with a neutralizing recombinant antibody to C5

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Targeting fibroblast-like synovial cells at sites of inflammation with peptide targeted liposomes results in inhibition of experimental arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2015.17

Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol

31 March 2020

1 reference

12 December 2020

Promising new treatments for rheumatoid arthritis - the kinase inhibitors

1 reference

12 December 2020

Vascular endothelium--role in chronic inflammatory disease

1 reference

12 December 2020

Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re

1 reference

12 December 2020

Long-circulating and target-specific nanoparticles: theory to practice

1 reference

12 December 2020

Integrin alpha V beta 3 as a target for treatment of rheumatoid arthritis and related rheumatic diseases

1 reference

12 December 2020